| Rhonda Mose, APRN-CNP | |
|
11900 Nw Expressway, Yukon, OK 73099-8795 | |
| (405) 283-9300 | |
| (405) 283-9301 |
| Full Name | Rhonda Mose |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 11 Years |
| Location | 11900 Nw Expressway, Yukon, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023433901 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | 86336 (Oklahoma) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | R0086336 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Oklahoma City, Inc | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic Oklahoma Communities | 1153468921 | 485 |
News Archive
Tau Therapeutics LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors, announced today that it has opened enrollment for a Phase Ib clinical trial with the National Cancer Institute's Adult Brain Tumor Consortium (ABTC) using the company's first product candidate mibefradil.
Soligenix, Inc., a development stage biopharmaceutical company, announced today results from long-term stability studies of its proprietary DNI anthrax rPA subunit protein vaccine, known as SGX204.
According to preliminary results from a new study, nighttime light exposure during sleep may affect metabolic function. The aim of this study was to test the hypothesis that light exposure at night during sleep adversely impacts metabolic outcomes.
After the new Victorian government said that there is a "black hole" in funding the project, the proposed Olivia Newton-John Cancer Centre in Melbourne may face difficulties in coming into being. About 2000 Victorians are expected to receive treatment at the centre, which was due to open in early 2013.
The Sandra Day O'Connor College of Law at Arizona State University has been named a regional office for the national Public Health Law Network, which launches today to provide legal and policy solutions to professionals grappling with complex public health challenges such as food safety, health reform and emergency preparedness.
› Verified 9 days ago
| Entity Name | Mercy Clinic Oklahoma Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386874550 PECOS PAC ID: 1153468921 Enrollment ID: O20091027000755 |
News Archive
Tau Therapeutics LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors, announced today that it has opened enrollment for a Phase Ib clinical trial with the National Cancer Institute's Adult Brain Tumor Consortium (ABTC) using the company's first product candidate mibefradil.
Soligenix, Inc., a development stage biopharmaceutical company, announced today results from long-term stability studies of its proprietary DNI anthrax rPA subunit protein vaccine, known as SGX204.
According to preliminary results from a new study, nighttime light exposure during sleep may affect metabolic function. The aim of this study was to test the hypothesis that light exposure at night during sleep adversely impacts metabolic outcomes.
After the new Victorian government said that there is a "black hole" in funding the project, the proposed Olivia Newton-John Cancer Centre in Melbourne may face difficulties in coming into being. About 2000 Victorians are expected to receive treatment at the centre, which was due to open in early 2013.
The Sandra Day O'Connor College of Law at Arizona State University has been named a regional office for the national Public Health Law Network, which launches today to provide legal and policy solutions to professionals grappling with complex public health challenges such as food safety, health reform and emergency preparedness.
› Verified 9 days ago
| Entity Name | Mercy Hospital Logan County, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306126818 PECOS PAC ID: 4587836200 Enrollment ID: O20121004000289 |
News Archive
Tau Therapeutics LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors, announced today that it has opened enrollment for a Phase Ib clinical trial with the National Cancer Institute's Adult Brain Tumor Consortium (ABTC) using the company's first product candidate mibefradil.
Soligenix, Inc., a development stage biopharmaceutical company, announced today results from long-term stability studies of its proprietary DNI anthrax rPA subunit protein vaccine, known as SGX204.
According to preliminary results from a new study, nighttime light exposure during sleep may affect metabolic function. The aim of this study was to test the hypothesis that light exposure at night during sleep adversely impacts metabolic outcomes.
After the new Victorian government said that there is a "black hole" in funding the project, the proposed Olivia Newton-John Cancer Centre in Melbourne may face difficulties in coming into being. About 2000 Victorians are expected to receive treatment at the centre, which was due to open in early 2013.
The Sandra Day O'Connor College of Law at Arizona State University has been named a regional office for the national Public Health Law Network, which launches today to provide legal and policy solutions to professionals grappling with complex public health challenges such as food safety, health reform and emergency preparedness.
› Verified 9 days ago
| Entity Name | True North Health Navigation Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740622133 PECOS PAC ID: 5294960696 Enrollment ID: O20180220002909 |
News Archive
Tau Therapeutics LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors, announced today that it has opened enrollment for a Phase Ib clinical trial with the National Cancer Institute's Adult Brain Tumor Consortium (ABTC) using the company's first product candidate mibefradil.
Soligenix, Inc., a development stage biopharmaceutical company, announced today results from long-term stability studies of its proprietary DNI anthrax rPA subunit protein vaccine, known as SGX204.
According to preliminary results from a new study, nighttime light exposure during sleep may affect metabolic function. The aim of this study was to test the hypothesis that light exposure at night during sleep adversely impacts metabolic outcomes.
After the new Victorian government said that there is a "black hole" in funding the project, the proposed Olivia Newton-John Cancer Centre in Melbourne may face difficulties in coming into being. About 2000 Victorians are expected to receive treatment at the centre, which was due to open in early 2013.
The Sandra Day O'Connor College of Law at Arizona State University has been named a regional office for the national Public Health Law Network, which launches today to provide legal and policy solutions to professionals grappling with complex public health challenges such as food safety, health reform and emergency preparedness.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rhonda Mose, APRN-CNP 11900 Nw Expressway, Yukon, OK 73099-8795 Ph: (405) 283-9300 | Rhonda Mose, APRN-CNP 11900 Nw Expressway, Yukon, OK 73099-8795 Ph: (405) 283-9300 |
News Archive
Tau Therapeutics LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors, announced today that it has opened enrollment for a Phase Ib clinical trial with the National Cancer Institute's Adult Brain Tumor Consortium (ABTC) using the company's first product candidate mibefradil.
Soligenix, Inc., a development stage biopharmaceutical company, announced today results from long-term stability studies of its proprietary DNI anthrax rPA subunit protein vaccine, known as SGX204.
According to preliminary results from a new study, nighttime light exposure during sleep may affect metabolic function. The aim of this study was to test the hypothesis that light exposure at night during sleep adversely impacts metabolic outcomes.
After the new Victorian government said that there is a "black hole" in funding the project, the proposed Olivia Newton-John Cancer Centre in Melbourne may face difficulties in coming into being. About 2000 Victorians are expected to receive treatment at the centre, which was due to open in early 2013.
The Sandra Day O'Connor College of Law at Arizona State University has been named a regional office for the national Public Health Law Network, which launches today to provide legal and policy solutions to professionals grappling with complex public health challenges such as food safety, health reform and emergency preparedness.
› Verified 9 days ago
Mr. Zachary Adam Smith, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1445 Health Center Pkwy, Yukon, OK 73099 Phone: 405-577-6701 | |
Priya John, NURSE PRACTITIONER Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 900 Justin Dr, Yukon, OK 73099 Phone: 405-473-3058 | |
Angie Osborn, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 508 W Vandament Ave Ste 100, Yukon, OK 73099 Phone: 405-350-8100 | |
Amanda Oblander, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 520 S Mustang Rd, Yukon, OK 73099 Phone: 405-936-5910 Fax: 405-577-2605 | |
Mrs. Crystal Jean Oneal, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10337 Paisley Rd, Yukon, OK 73099 Phone: 405-408-9753 | |
Rhea Frans, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1205 Health Center Pkwy Ste 240b, Yukon, OK 73099 Phone: 405-717-5496 Fax: 405-717-5320 |